Atopic Dermatitis Treatment Market revenue is set to expand at a CAGR of 12.8% over the forecast period 2017–2027

Future Market Insights (FMI) in its new report projects that the global market for atopic dermatitis treatment will at a double-digit CAGR of 12.8% between 2017 and 2027. Increasing occurrence of atopic dermatitis in recent years has resulted in higher demand for its treatment. Furthermore, the development of novel therapeutic and drugs is also supporting the growth of the global market for atopic dermatitis treatment. This market is projected to surpass a valuation of US$ 23,990 Mn towards the end of the assessment period. Over the years, atopic dermatitis treatment has improved and has become more effective owing incessant research and development of more efficient drugs. At the same time, introduction of revised reimbursement policies is facilitating a quicker initiation of the treatment. Factors as such are expected to reflect favorably on the global market for atopic dermatitis treatment.

Request and Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3097

North America a Key Market for Atopic Dermatitis Treatment : Among regions, the market in the North America region is anticipated to exhibit significant growth throughout the projection period. In terms of revenue, the region accounted for around 30% share of the market in 2016. During 2017 to 2027, the region’s market is projected to surge at 16% CAGR and surpass a valuation of US$ 10,380 Mn. North America is followed by Western Europe. Being the second largest market, Western Europe is attractive destination for many of the leading pharma companies. These companies are actively focusing of gaining a greater foothold in the region by acquiring local players having expertise in dermatology offerings. Meanwhile, the market is Asia-Pacific excluding Japan (APEJ) is also expected to register sizeable growth in the forthcoming years.

Key Takeaways From the Report Include: On the basis of drug class, the corticosteroids segment currently command for the largest market share in terms of revenue. Although, the segment is expected to lose a considerable amount ground to the PDE-4 inhibitor and the biologic therapy segments by the end of 2027. The On the basis of administration mode, preference for topical procedures will be relatively stronger as compared to injectable and oral injectable administration mode in 2017 and beyond. By the end of the assessment period, over two-third market share will accounted to drug administration through topical procedures.Based on distribution channel, hospital pharmacies will continue to be the largest segment despite the quick proliferation of dermatology clinics. The hospital pharmacies segment currently command for around 33% share of the market, which is projected incur a miniscule drop and settle for approximately 31.4% by 2027-end.

Request Report Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-3097

Competitive Analysis : FMI’s report has mentioned some of the key players functioning in the global market for atopic dermatitis, which includes; Biofrontera AG, Galderma SA, Novartis, Bayer AG, Astellas Pharma Inc., Regeneron Pharmaceuticals, Pfizer, Connetics Corporation, Encore Dermatology, Velite Pharmaceutical, Sanofi SA, Allergan Plc., Bristol-Myers Squibb, Meda Pharmaceuticals, Anacor Pharmaceutical Inc., Aqua Pharmaceuticals (An Almirall Company), Dow Pharm, Fujisawa Healthcare, and LEO Pharma. A majority of these companies are making strategic acquisition to increasing their product offerings and maintain a competitive edge.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

This release was published on openPR.